In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Koselugois a small molecule inhibitory drug targeting the MEK signaling pathway,···【more】
Release date:2024-08-21Recommended:428
Koselugo, as a small molecule blocker of the MEK signaling pathway, has a core e···【more】
Release date:2024-08-21Recommended:477
Koselugo is a small molecule inhibitor targeting the MEK signaling pathway, main···【more】
Release date:2024-08-21Recommended:454
Koselugo is a small molecule inhibitor targeting MEK, which plays the role of a ···【more】
Release date:2024-08-21Recommended:405
Koselugo is a small molecule MEK inhibitor and a repressor of mitogen activation···【more】
Release date:2024-08-21Recommended:411
Koselugois a small molecule MEK inhibitor (mitogen activation inhibitor), and it···【more】
Release date:2024-08-21Recommended:396
The therapeutic effect of Mitotane is aimed at adrenal cortical carcinoma, hyper···【more】
Release date:2024-08-20Recommended:420
Anamorelin is the first drug specifically for the treatment of cachexia launched···【more】
Release date:2024-08-20Recommended:356
In 2021, Japan launched Anamorelin, the world's first drug specifically for ···【more】
Release date:2024-08-20Recommended:469
Anamorelin is the world's first drug specifically for the treatment of cache···【more】
Release date:2024-08-20Recommended:487
In 2021, Ono Pharmaceutical of Japan launched Anamorelin, a ghrelin receptor ago···【more】
Release date:2024-08-20Recommended:516
Anamorelin is the first cachexia treatment drug launched in Japan in 2021, which···【more】
Release date:2024-08-20Recommended:502